文献速递脊柱关节炎

中轴型脊柱关节炎残余疾病与未来复发风险的关联:纵向研究

The association between residual disease and the risk of future disease flares in axial spondyloarthritis: A longitudinal study.
PubMed 文献 · Semin Arthritis Rheum · 2026-04-08

该前瞻性纵向研究纳入135例处于无活动或低疾病活动度(ID/LDA)的中轴型脊柱关节炎(axSpA)患者,评估残余疾病是否增加未来12个月内复发风险。结果显示患者体验的残余疾病在低教育水平患者中与复发风险升高及复发时间缩短相关,而客观残余疾病无此关联。

要点

  • 多数ID/LDA状态axSpA患者存在患者体验或客观残余疾病。
  • 患者体验的残余疾病在低教育水平患者中预测复发。
  • 客观残余疾病与复发发生或时间均无关联。

核心结论

  • 在低教育水平的axSpA患者中,患者体验的残余疾病(而非客观残余疾病)预测未来复发,提示残余症状具有预后相关性。

研究设计与样本

  • 前瞻性纵向研究,使用SpA-Net网络监测系统数据,纳入135例处于ID/LDA(ASDAS<2.1)的axSpA患者。

主要发现

  • 135例患者中80例(62.5%)有患者体验的残余疾病,60例(60.0%)有客观残余疾病。
  • 调整分析中,低教育水平患者体验的残余疾病与复发风险升高相关(OR=17.7,95%CI 2.1-147.5),与复发时间缩短相关(HR=12.1,95%CI 1.6-91.9)。
  • 客观残余疾病与复发发生及复发时间均无关联。

关键数值与推荐

  • 残余疾病定义:ID/LDA状态下存在≥1项患者体验指标(疲劳、背痛和/或躯体功能NRS≥4/10)或客观指标(活动性外周表现、活动性银屑病、CRP升高和/或医生总体评估NRS≥2/10)。
  • 复发定义:ASDAS增加≥0.9且从ID/LDA转为高疾病活动度(ASDAS≥2.1)。
  • ID/LDA定义:ASDAS<2.1。

临床怎么用

  • 对处于ID/LDA的axSpA患者,应关注患者报告的残余症状(疲劳、背痛、躯体功能下降),尤其对低教育水平患者,其复发风险更高。

局限性

  • 样本量较小(135例),部分关联的置信区间较宽,结果需外部验证。
  • 残余疾病与复发关联仅在低教育水平亚组中显著,其他亚组未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess, in patients with axial spondyloarthritis (axSpA), whether the presence of clinically relevant signs or symptoms ('residual disease') while in an inactive disease or low disease activity (ID/LDA) state increases the risk of future disease flares. METHODS: Prospective data were used from SpA-Net, a web-based monitoring system for SpA. Residual disease was defined as the presence of ≥1 patient-experienced indicator (fatigue, back pain, and/or physical function NRS ≥4/10) or objective indicator (active peripheral manifestations, active psoriasis, elevated CRP, and/or physician global assessment NRS ≥2/10) of disease, while in ID/LDA (AxSpA Disease Activity Score [ASDAS] <2.1). A flare was defined as an ASDAS increase ≥0.9 and shift from ID/LDA to high disease activity (ASDAS ≥2.1). Multivariable logistic and Cox regression analyses investigated the association between residual disease and (time to) subsequent flares within 12 months. RESULTS: Among 135 patients (mean age 50.1 ± 13.2 years, 53 [39.3%] females), 80 (62.5%) and 60 (60.0%) had patient-experienced and objective residual disease, respectively. Thirty-four patients (25.2%) experienced a flare, after a mean of 190 (SD 97) days. In adjusted analyses, patient-experienced residual disease in those with lower education levels was associated with an increased risk of flares (OR = 17.7, 95%CI 2.1-147.5), and a shorter time-to-flare (HR = 12.1, 95%CI 1.6-91.9). Objective residual disease was not associated with the occurrence nor time-to-flare. CONCLUSION: The majority of axSpA patients in an ID/LDA state have patient-experienced or objective residual disease. Patient-experienced, but not objective, residual disease predicts flares in patients with lower education levels, suggesting prognostic relevance of residual symptoms in axSpA.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Renet E, Smits ML, van Tubergen A, et al. The association between residual disease and the risk of future disease flares in axial spondyloarthritis: A longitudinal study. Semin Arthritis Rheum. 2026. PMID: 41990461. doi:10.1016/j.semarthrit.2026.152980

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。